JSE slips as investors consider new Covid-19 vaccine developments

The JSE was weaker on Tuesday, with its global peers mixed as investors digest another Covid-19 vaccine announcement, while new restrictions are being implemented.

The stock markets received a boost on Monday after Moderna said that its preliminary phase 3 trial data showed its Covid-19 vaccine was more than 94% effective. Moderna’s announcement comes a week after Pfizer and BioNTech announced their vaccine trial results.

Source: businesslive.co.za